Introduction
Cold coagulation of the cervical transformation zone is known to be an effective treatment for all grades of cervical intraepithelial neoplasia.' It is associated with low morbidity and preservation of fertility. Financial outlay, maintenance and running costs of the equipment are significantly less than some other treatment modalities.
Of the 189 genitourinary medicine clinics in England and Wales, 60 provide a colposcopy service of which around 50% offer treatment, cold coagulation being the commonest method. 2 The Department of Genitourinary Medicine (GUM) at the Royal Liverpool University Hospital set up a colposcopy service in 1985. Three years later it acquired a "Semm" cold coagulator, prior to which all women with CIN requiring treatment were referred to the Department of Gynaecology. There is now access to a laser, and a Lletz diathermy machine was acquired by the Department in September 1989.
This study was conducted after a preliminary report3 concluded that cold coagulation should be a treatment modality in genitourinary medicine. It aims to show that the outcome of cold coagulation of the transformation zone for major cervical lesions (cervical intraepithelial neoplasia 2 and 3) used within a GUM colposcopy clinic is comparable with that of other specialities.
Patients and methods All patients who attended the GUM outpatients clinic with abnormal cytology, genital warts or exposure to, herpes genitalis, and "suspicious" cervix between February 1988 and October 1989 were offered colposcopic examination of the cervix. They were counselled and given information sheets at the time of booking for colposcopy.
Colposcopy (with a Zeiss OPM I-1) was performed as described elsewhere.4 The squamo-columnar junction was identified in its entirety and biopsy specimens were taken from aceto-white areas with punch biopsy forceps. The specimens were fixed in formalin. The patient was advised to return to the clinic after six weeks. Subsequent management depended on the histology, fulfilment of criteria for out-patient ablative therapy and patients suitability for cold coagulation.
Cold coagulation was performed at 100°C, with overlapping applications each lasting 20 seconds, to the entire transformation zone and inner canal. No analgesia was used. "Sultrin" vaginal cream was prescribed for 1 week after treatment.
Post treatment follow-up cytology was initially performed at 4, 8 and 12 months. A revised cytological follow-up policy was instigated in January 1989, with smears taken at 6 and 12 months respectively. Final colposcopic assessment was performed at 18 months.
Intervention, in the form of re-colposcopy was performed if cytology on two occasions 
Results offinal colposcopy
Seventy patients had completed the eighteen month programme. At colposcopy, 55 patients had normal transformation zones, and were advised to continue with regular cytological assessments on an annual basis. Abnormal transformation zones were observed in twelve patients, three patients had no evidence of CIN on cervical biopsy, whilst nine patients had CIN 1. Excision of No adverse effects were witnessed in either the short or long term. However, a proportion of women subsequently commented that they had experienced discomfort during treatment. Six women had subsequently had normal pregnancies and uncomplicated vaginal deliveries.
Attendance for follow-up was excellent, despite the lack of a formal computerised recall system. It was felt that this was partly patient motivation, but reviewing all case sheets for this group and recalling non-attenders did play a part in achieving an overall 83.7% attendance.
The value of final colposcopic examination is equivocal. The pick-up rate of abnormalities in this series was 7.04% (5 cases) and were of a minor degree of CIN. No microinvasive or glandular disease had become apparent in this series.
Many women expressed anxiety over the length of follow-up especially when it culminated in a colposcopic examination. In contrast, a proportion of women valued the reassurance of a normal final colposcopy.
As a majority of treatment failures were picked up early, we feel that follow-up colposcopy should be performed within a year of treatment with subsequent annual cytological follow-up for 
